<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">Rodent models</z:e> of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> are essential tools in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> research </plain></SENT>
<SENT sid="1" pm="."><plain>They have added tremendously to our understanding of injury mechanisms in <z:hpo ids='HP_0001297'>stroke</z:hpo> and have helped to identify potential therapeutic targets </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:hpo ids='HP_0001050'>plethora</z:hpo> of substances, however, in particular an overwhelming number of putative neuroprotective agents, have been shown to be effective in preclinical <z:hpo ids='HP_0001297'>stroke</z:hpo> research, but have failed in clinical trials </plain></SENT>
<SENT sid="3" pm="."><plain>A lot of factors may have contributed to this failure of translation from bench to bedside </plain></SENT>
<SENT sid="4" pm="."><plain>Often, deficits in the quality of experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> research seem to be involved </plain></SENT>
<SENT sid="5" pm="."><plain>In this article, we review the commonest <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> - middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, photothrombosis, and embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> models - with their respective advantages and problems, and we address the issue of quality in preclinical <z:hpo ids='HP_0001297'>stroke</z:hpo> modeling as well as potential reasons for translational failure </plain></SENT>
</text></document>